AFFIMED
At Affimed, they are committed to improving outcomes for patients with cancer. Their scientific team has been devoted to unlocking the power of the innate immune system for nearly two decades to provide a unqiue approach to fighting cancer. With their unparalleled expertise in innate immunity and innate cell engager-based medicines, they aim to overcome the limitations and challenges faced by current immuno-oncology (I-O) therapies.
AFFIMED
Industry:
Biotechnology Clinical Trials Health Care Medical Therapeutics
Founded:
2000-01-01
Address:
Heidelberg, Baden-Wurttemberg, Germany
Country:
Germany
Website Url:
http://www.affimed.com
Total Employee:
51+
Status:
Active
Contact:
+49 (0)6221-6743-60
Email Addresses:
[email protected]
Total Funding:
534.03 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon WordPress Font Awesome Mobile Non Scaleable Content HSTS Organization Schema Sitelinks Search Box Yoast WordPress SEO Plugin
Similar Organizations
Agenus
Agenus develops and commercializes immunotherapies and vaccines for cancer and infectious diseases.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
argenx
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.
bit.bio
Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell.
Bright Peak Therapeutics
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
Castor
Castor offers a cloud-based clinical data platform that simplifies and streamlines clinical trials processes.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
UniQure
uniQure is focused on the research and early development of human gene-based therapies.
Verona Pharma
Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases.
Viking Therapeutics
Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.
Current Employees Featured
Founder
Stock Details
Investors List
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Affimed
Roche
Roche investment in Post-IPO Equity - Affimed
Aeris Capital
Aeris Capital investment in Post-IPO Equity - Affimed
German Federal Ministry of Education and Research
German Federal Ministry of Education and Research investment in Grant - Affimed
Perceptive Advisors
Perceptive Advisors investment in Debt Financing - Affimed
BioMedPartners
BioMedPartners investment in Series E - Affimed
OrbiMed
OrbiMed investment in Series E - Affimed
Novo Holdings
Novo Holdings investment in Series E - Affimed
Aeris Capital
Aeris Capital investment in Series E - Affimed
EQT Life Sciences
EQT Life Sciences investment in Series E - Affimed
Official Site Inspections
http://www.affimed.com Semrush global rank: 3.3 M Semrush visits lastest month: 4.28 K
- Host name: 217-160-0-75.elastic-ssl.ui-r.com
- IP address: 217.160.0.75
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Affimed"
Affimed Announces Leadership Change and Organizational …
Jan 8, 2024 Go forward organization will focus on advancing clinical programs; Company …See details»
Corporate Governance - Affimed
Affimed Announces Leadership Change and Organizational …
Jan 8, 2024 Affimed N.V. Dr. Adi Hoess to step down as CEO and Management Board …See details»
Affimed Announces Leadership Change and Organizational …
Jan 8, 2024 Andreas Harstrick appointed Interim CEOStrategic restructuring reducing …See details»
Affimed - Crunchbase Company Profile & Funding
Organization. Affimed . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of …See details»
Affimed - LinkedIn
Affimed N.V. (Nasdaq: AFMD) is a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer by actualizing the untapped potential of the innate ...See details»
Webcasts and Corporate Presentation - Affimed
See how Affimed is putting our proven track record of innovation into practice. View our …See details»
Affimed N.V. (AFMD) Company Profile & Overview - Stock Analysis
Nov 21, 2024 Affimed N.V., a clinical-stage biopharmaceutical company, focuses on …See details»
Affimed Company Profile 2024: Stock Performance & Earnings
Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in …See details»
Affimed Announces Oral Presentation of Phase 1/2 Data from …
Nov 2, 2023 Affimed Announces Oral Presentation of Phase 1/2 Data from AFM13 in …See details»
Affimed Announces Updated Phase 1/2 Data from Acimtamig in …
Dec 11, 2023 Affimed N.V. In 32 patients with relapsed/refractory (r/r) Hodgkin lymphoma …See details»
About us - Affimed
Affimed fosters and continues to seek partnerships that align with the company’s overall …See details»
Affimed Announces Leadership Change and Organizational
Jan 8, 2024 Affimed also announced today a restructuring initiative aimed at transforming the …See details»
Affimed Receives FDA Fast Track Designation for AFM13 in …
Sep 12, 2023 Affimed N.V. AFM13 in combination with AlloNK® (also known as AB-101) will …See details»
News and Events - Affimed
Affimed to Present at the Cantor Global Healthcare Conference 2024. September 10, 2024. …See details»
Affimed - Gilde Healthcare
Affimed (Nasdaq: AFMD) is a clinical-stage immuno-oncology company committed to giving …See details»
Affimed Announces Acimtamig as International Nonproprietary …
MANNHEIM, Germany, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) …See details»
Innately Affimed - Affimed
That define Affimed and drive our unrelenting spirit in the fight against cancer. Culture Explore …See details»